Vanderbilt Ingram Cancer Center, Nashville TN; Duke Oncology Network, Durham, NC; University of Michigan Comprehensive Cancer Center, Ann Arbor MI; American Society of Clinical Oncology, Alexandria, VA; Oncology Nursing Society, Pittsburgh, PA; Oncology Nursing Consultant, New Orleans, LA; and Dana Farber Cancer Institute, Boston, MA.
J Oncol Pract. 2013 Mar;9(2 Suppl):5s-13s. doi: 10.1200/JOP.2013.000874.
In 2009, ASCO and the Oncology Nursing Society (ONS) published standards for the safe use of parenteral chemotherapy in the outpatient setting, including issues of practitioner orders, preparation, and administration of medication. In 2011, these were updated to include inpatient facilities. In December 2011, a multistakeholder workgroup met to address the issues associated with orally administered antineoplastics, under the leadership of ASCO and ONS. The workgroup participants developed recommended standards, which were presented for public comment. Public comments informed final edits, and the final standards were reviewed and approved by the ASCO and ONS Boards of Directors. Significant newly identified recommendations include those associated with drug prescription and the necessity of ascertaining that prescriptions are filled. In addition, the importance of patient and family education regarding administration schedules, exception procedures, disposal of unused oral medication, and aspects of continuity of care across settings were identified. This article presents the newly developed standards.
2009 年,美国临床肿瘤学会(ASCO)和肿瘤护理学会(ONS)发布了门诊环境中安全使用静脉化疗药物的标准,其中包括从业者医嘱、药物准备和管理等问题。2011 年,这些标准进行了更新,纳入了住院设施。2011 年 12 月,在 ASCO 和 ONS 的领导下,一个多利益相关方工作组开会解决口服抗肿瘤药物相关问题。工作组参与者制定了推荐标准,并进行了公开征求意见。公众意见为最终修订提供了参考,最终标准由 ASCO 和 ONS 董事会审查和批准。新确定的重要建议包括与药物处方相关的建议,以及确定处方已被执行的必要性。此外,还确定了患者和家属在管理时间表、例外程序、未使用口服药物的处理以及不同环境下护理连续性等方面的教育的重要性。本文介绍了新制定的标准。